Differential pattern of endothelin-1-induced inotropic effects in right atria and left ventricles of the human heart

被引:8
作者
Dhein, S
Giessler, C
Wangemann, T
Silber, RE
Zerkowski, HR
Brodde, OE
机构
[1] Univ Halle Wittenberg, Inst Pharmacol, Dept Pharmacol, D-06097 Halle, Germany
[2] Univ Halle Wittenberg, Dept Cardiothorac Surg, D-06097 Halle, Germany
关键词
endothelin-ETA receptor; ETB receptor; human heart;
D O I
10.1097/00005344-200011000-00004
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
In human right atrium, endothelin A (ETA) receptors couple to both inositol phosphate formation and inhibition of adenylylcyclase. whereas in human left ventricle, ETA receptors couple only to inositol phosphate formation. To find out whether this might be of functional relevance, Eve studied, in right atria obtained from 32 patients undergoing coronary bypass grafting without apparent heart failure, and in right atria and left ventricles from eight patients with end-stage heart failure (NYHA TV) undergoing heart transplantation, the effects of endothelin-1 (ET-1) on basal force of contraction or on force of contraction increased by 1 muM forskolin. ET-I (0.1 muM) exerted a positive inotropic effect in atrial and ventricular tissue; this could be antagonized by the ETA-receptor antagonist BQ 123, but not by the ETB-receptor antagonist BQ 788. In atrial, but not in ventricular tissue, this positive inotropic effect was preceded by a transient negative inotropic effect. This negative inotropic effect was inhibited by BQ 123, but not by BQ 788. It was significantly prolonged in forskolin-prestimulated atria, and was significantly larger in atria from failing hearts. We conclude that, because ET-1 inhibits adenylylcyclase and causes negative inotropic effects in atria but not in ventricles, adenylylcyclase inhibition might be responsible for the transient negative inotropic effect of ET-1.
引用
收藏
页码:564 / 569
页数:6
相关论文
共 32 条
[1]
ENDOTHELIN RECEPTORS IN THE HUMAN CORONARY-ARTERY, VENTRICLE AND ATRIUM - A QUANTITATIVE AUTORADIOGRAPHIC ANALYSIS [J].
BAX, WA ;
BRUINVELS, AT ;
VANSUYLEN, RJ ;
SAXENA, PR ;
HOYER, D .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1993, 348 (04) :403-410
[2]
INOSITOL PHOSPHATES AND CELL SIGNALING [J].
BERRIDGE, MJ ;
IRVINE, RF .
NATURE, 1989, 341 (6239) :197-205
[3]
ALTERATIONS OF BETA-ADRENOCEPTOR-G-PROTEIN-REGULATED ADENYLYL-CYCLASE IN HEART-FAILURE [J].
BOHM, M .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1995, 147 (1-2) :147-160
[4]
INCREASE OF GI-ALPHA IN HUMAN HEARTS WITH DILATED BUT NOT ISCHEMIC CARDIOMYOPATHY [J].
BOHM, M ;
GIERSCHIK, P ;
JAKOBS, KH ;
PIESKE, B ;
SCHNABEL, P ;
UNGERER, M ;
ERDMANN, E .
CIRCULATION, 1990, 82 (04) :1249-1265
[5]
SIGNAL-TRANSDUCTION MECHANISMS CONTROLLING CARDIAC CONTRACTILITY AND THEIR ALTERATIONS IN CHRONIC HEART-FAILURE [J].
BRODDE, OE ;
MICHEL, MC ;
ZERKOWSKI, HR .
CARDIOVASCULAR RESEARCH, 1995, 30 (04) :570-584
[6]
Burrell KM, 2000, J PHARMACOL EXP THER, V292, P449
[7]
CLOZEL M, 1994, J PHARMACOL EXP THER, V270, P228
[8]
Is there a role for endothelin in the natural history of heart failure? [J].
Cohn, JN .
CIRCULATION, 1996, 94 (04) :604-606
[9]
FELDMAN AM, 1993, CIRCULATION, V87, P27
[10]
Muscarinic receptors in the failing human heart [J].
Giessler, C ;
Dhein, S ;
Pönicke, K ;
Brodde, OE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 375 (1-3) :197-202